Cannara Biotech (OTCMKTS:CNBTF) Shares Up 0.7% – What’s Next?

Cannara Biotech (OTCMKTS:CNBTFGet Free Report) was up 0.7% during trading on Thursday . The company traded as high as $1.44 and last traded at $1.44. Approximately 5,001 shares traded hands during trading, a decline of 85% from the average daily volume of 33,127 shares. The stock had previously closed at $1.4305.

Cannara Biotech Price Performance

The firm’s 50-day moving average price is $1.35 and its two-hundred day moving average price is $1.31.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.

Featured Stories

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.